Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.324
+0.004 (1.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Biomerica Revenue
Biomerica had revenue of $1.81M in the quarter ending August 31, 2024, with 5.49% growth. This brings the company's revenue in the last twelve months to $5.51M, up 1.74% year-over-year. In the fiscal year ending May 31, 2024, Biomerica had annual revenue of $5.42M with 1.42% growth.
Revenue (ttm)
$5.51M
Revenue Growth
+1.74%
P/S Ratio
0.99
Revenue / Employee
$86,078
Employees
64
Market Cap
5.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2024 | 5.42M | 76.00K | 1.42% |
May 31, 2023 | 5.34M | -13.53M | -71.71% |
May 31, 2022 | 18.87M | 11.67M | 162.13% |
May 31, 2021 | 7.20M | 506.32K | 7.57% |
May 31, 2020 | 6.69M | 1.49M | 28.69% |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
May 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Applied DNA Sciences | 3.40M |
Kindly MD | 2.88M |
Mainz Biomed | 917.20K |
Mangoceuticals | 755.00K |
Cyclerion Therapeutics | 194.00K |
Organovo Holdings | 103.00K |
BMRA News
- 1 hour ago - Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis - GlobeNewsWire
- 14 days ago - Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements - GlobeNewsWire
- 22 days ago - Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - GlobeNewsWire
- 5 weeks ago - Biomerica Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 2 months ago - The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - GlobeNewsWire
- 3 months ago - Biomerica Reports Fiscal 2024 Year End Results - GlobeNewsWire
- 5 months ago - Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - GlobeNewsWire
- 6 months ago - Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 - GlobeNewsWire